{
  "trial_id": "NCT00581529",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "unifocal histologically proven breast cancer",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "calcifications in mammogram",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "DCIS (Ductal carcinoma in situ) (Tis, Stage 0)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Non-lobular infiltrating carcinoma, maximum of 2 cm in diameter.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "The patient was operated on and the tumor was excised with lumpectomy",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The tumor is reported with negative margins >3 mm, as per our hospital protocol.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "For invasive carcinoma, axillary lymph nodes are negative by sentinel lymph node (SLN) mapping and biopsy or by formal axillary lymph node dissection.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The patient is over 40 years old with life expectancy of at least 5 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Karnofsky status must be at least 70.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pre- and post-menopausal women are eligible for entry.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The patient must be aware of the neoplastic nature of her disease and must be willing to consent after being informed of the potential benefits, side effects and risks of radiotherapy.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Institutional Review Board approval of this protocol and a consent form is required.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "No concurrent or neoadjuvant chemotherapy is allowed.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with diffuse calcifications, multifocal or multicentric disease, lymph-vascular invasion are excluded.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Patients cannot participate if there is extensive LCIS (Lobular carcinoma in situ) in specimen or extensive DCIS.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Patients are excluded if systemic disease is present or the patient has been irradiated to the ipsilateral breast or the chest wall.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Pregnant woman cannot participate in the study.",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient is a 42 year-old postmenopausal woman with a history of breast cancer, who has undergone lumpectomy and has negative margins. She has no concurrent or neoadjuvant chemotherapy and does not have diffuse calcifications, multifocal or multicentric disease, lymph-vascular invasion, extensive LCIS (Lobular carcinoma in situ) in specimen or extensive DCIS.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT00581529",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}